Skip to main content
Strategic Partners A/S logo

Strategic Partners A/S — Investor Relations & Filings

Ticker · STRAP ISIN · DK0062502894 LEI · 54930025OZD2GGSQ7L42 CO Financial and insurance activities
Open in API
Filings indexed 501 across all filing types
Latest filing 2021-03-02 Remuneration Information
Country DK Denmark
Listing CO STRAP

About Strategic Partners A/S

https://www.strategic-partners.dk/

Strategic Partners A/S is an investment company that engages in strategic partnerships with businesses that have significant potential. The company's strategy involves taking an active ownership role to create value through its competencies. In addition to its primary focus, the firm may also invest in other equity interests and properties to generate returns. Formerly known as Orphazyme A/S, the company sold its biotechnology activities in May 2022. A new board and management team was appointed in May 2023, and the company officially adopted its new strategy, purpose, and name in October 2024.

Recent filings

Filing Released Lang Actions
Orphazyme reports business highlights and financial results in Annual Report 2020
Remuneration Information Classification · 100% confidence The document is explicitly titled '2020 Remuneration Report' for Orphazyme. It details the compensation structure, fixed fees, share-based incentive programs, and travel allowances for the Board of Directors and Executive Management. It references compliance with the Danish Companies Act and corporate governance recommendations regarding remuneration. This document is a standalone report on executive and board compensation, which falls under the 'Remuneration Information' category.
2021-03-02 English
Orphazyme reports business highlights and financial results in Annual Report 2020
Annual Report Classification · 100% confidence The document is explicitly titled 'ANNUAL REPORT 2020' and contains comprehensive sections including a letter from the chairman, key financial figures, detailed financial statements (consolidated profit or loss, financial position, cash flows), notes to financial statements, and an independent auditor's report. It covers the full fiscal year 2020 and provides a detailed review of company activities, governance, and financial performance, fitting the definition of a 10-K (Annual Report). FY 2020
2021-03-02 English
Orphazyme reports business highlights and financial results in Annual Report 2020
Report Publication Announcement Classification · 100% confidence The document is a short (3-page) company announcement from Orphazyme A/S. It summarizes key business highlights and financial results for the 2020 fiscal year, but explicitly states that the full Annual Report 2020 is attached as a separate PDF file and provides a link to the company website. Following the 'Menu vs Meal' rule, this document is an announcement of a report rather than the report itself, making it a Report Publication Announcement (RPA).
2021-03-02 English
Report Publication Announcement 2020
Report Publication Announcement Classification · 100% confidence The document is a company announcement from Orphazyme A/S regarding the publication of their 2020 Annual Report. It provides a summary of business highlights, financial results, and upcoming events, but explicitly states that the full report is attached as a separate PDF file. According to the 'Menu vs Meal' rule, an announcement of a report's publication is classified as a Report Publication Announcement (RPA). FY 2020
2021-03-02 English
Orphazyme appoints Christophe Bourdon as Chief Executive Officer
Board/Management Information Classification · 100% confidence The document is a formal company announcement from Orphazyme A/S regarding the appointment of a new Chief Executive Officer, Christophe Bourdon. This falls directly under the category of management changes, which is defined as 'Announcement of changes in the company's board of directors or senior management'.
2021-03-01 English
Board/Management Information 2021
Board/Management Information Classification · 99% confidence The document is titled "Orphazyme appoints Christophe Bourdon as Chief Executive Officer" and is explicitly labeled as a "Company announcement" containing "Inside information." It details a change in senior management (CEO appointment). This directly corresponds to the definition of Board/Management Information (MANG). Although it is a formal announcement, it is not a general regulatory filing (RNS) or a report publication announcement (RPA) because the core content is the management change itself, not an announcement about a separate financial report.
2021-03-01 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.